Renowned Australian Melanoma Expert Richard Scolyer Dies After Experimental Brain-Cancer Trial

Renowned melanoma researcher Richard Scolyer died in Sydney at the age of 59 after a prolonged battle with glioblastoma. The BBC reported that he had been receiving an experimental immunotherapy treatment for the brain cancer, a trial that has spurred the launch of a new clinical study in the United States. His work in melanoma research had earned him international recognition.

The New York Times later confirmed his death and noted that a state funeral will be held in his honor. Officials said the ceremony will recognize his contributions to cancer research and his leadership at the Melanoma Institute Australia. Colleagues, including fellow researcher Georgina Long, expressed condolences for the loss of a leading pathologist.